Chlorambucil in the treatment of patients with immune‐mediated rheumatic diseases
- 1 March 1993
- journal article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 36 (3) , 325-328
- https://doi.org/10.1002/art.1780360306
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Pharmacological Management of Juvenile Rheumatoid ArthritisDrugs, 1992
- Preferential reductions in lymphocyte sub-populations induced by monthly pulses of chlorambucil: Studies in patients with chronic progressive multiple sclerosisInternational Journal of Immunopharmacology, 1991
- High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behcet's disease.British Journal of Ophthalmology, 1990
- Twenty cases of sympathetic ophthalmia.British Journal of Ophthalmology, 1989
- THE ONCOGENICITY OF CHLORAMBUCIL IN RHEUMATOID ARTHRITISRheumatology, 1988
- Malignancies induced by chlorambucilCancer Treatment Reviews, 1984
- Increased Incidence of Acute Leukemia in Polycythemia Vera Associated with Chlorambucil TherapyNew England Journal of Medicine, 1981
- Comparison of chlorambucil, azathioprine or cyclophosphamide combined with corticosteroids in the treatment of lupus nephritisBritish Journal of Dermatology, 1979
- Chlorambucil and LeukemiaNew England Journal of Medicine, 1977
- Favorable outcome in diffuse proliferative glomerulonephritis of systemic lupus erythematosusArthritis & Rheumatism, 1974